Filament CEO Ben Lightburn spoke to Maclean's Magazine about the innovative psychedelic drug development work that takes place at the Vancouver lab operated by our wholly-owned subsidiary Psilo Scientific.
Inside the Vancouver lab where scientists (legally) grow magic mushrooms
March 24, 2023
read more News
Filament Health Announces Interim Results From Phase I Clinical Trial At The University Of California San Francisco
May 30, 2023